The role of αv-integrins in tumour progression and metastasis

Seminars in Cancer Biology

Volumn 7, Issue 3, 1996, Pages 129-138

  Marshall, John F ^a   Hart, Ian R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cancer; Cell adhesion; Integrin; Protease

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DIMER; INTEGRIN; PROTEINASE;

ANGIOGENESIS; ANTIGEN EXPRESSION; CANCER INVASION; CELL ADHESION; CELL MIGRATION; EXTRACELLULAR MATRIX; MELANOMA CELL; METASTASIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; TUMOR CELL; TUMOR GROWTH;

EID: 0029996913     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0018     Document Type: Review

References (85)

1. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
2. Juliano RL, Varner JA (1993) Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5:812-818
3. Giancotti FG, Mainiero F (1994) Integrin-mediated adhesion and signalling in tumourigenesis. Biochim Biophys Acta 1198:47-64
4. Milner R, Ffrench-Constant C (1994) A developmental analysis of oligodendroglial integrins in primary-cells: changes in αv-associated β-subunits during differentiation. Development 120:3497-3506
5. 1). J Biol Chem 265:5934-5937
6. Cheresh DA, Spiro RC (1987) Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen and von Willebrand factor. J Biol Chem 262:17703-17711
7. x) is responsible for distinct adhesive properties of carcinoma cells. Cell 57:59-69
8. Busk M, Pytela R, Sheppard D (1992) Characterization of the integrin αvβ6 as a fibronectin-binding protein. J Biol Chem 267:5790-5796
9. Nishimura SL, Sheppard D, Pytela R (1994) Integrin αvβ8: Interaction with vitronectin and functional divergence of the β8 cytoplasmic domain. J Biol Chem 269:28708-28715
10. Bodary SC, McLean JW (1990) The integrin β1 subunit associates with the vitronectin receptor αv subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 265:5938-5941
11. Marshall JF, Rutherford DC, McCartney ACE, Mitjans F, Goodman SL, Hart IR (1995) αvβ1 is a receptor for vitronectin and fibrinogen and acts with α5β1 to mediate spreading on fibronectin. J Cell Sci 108:1227-1238
12. Bates RC, Rankin LM, Lucas CM, Scott JL, Krissansen GW, Burns GF (1991) Individual embryonic fibroblasts express multiple (5 chains in association with the αv integrin subunit. J Biol Chem 266:18593-18599
13. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM (1995) Adhesive and migratory effects of osteopontin are mediated via distinct cell-surface integrins: role of αvβ3 in smooth-muscle cell-migration to osteopontin in vitro. J Clin Invest 95:713-724
14. Delannet M, Martin F, Bossy B, Cheresh DA, Reichardt LF, Duband JL (1994) Specific roles of the αvβ1, αvβ3 and αvβ5 integrins in avian neural crest cell-adhesion and migration on vitronectin. Development 120:2687-2702
15. Zhang ZH, Vuori K, Reed JC, Ruoslahti E (1995) The α5β1 integrin supports survival of cells on fibronectin and upregulates bcl-2 expression. Proc Natl Acad Sci USA 92:6161-6165
16. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH (1995) Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129:867-879
17. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA (1992) Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 117:1101-1107
18. Klemke RL, Yebra M, Bayna EM, Cheresh DA (1994) Receptor tyrosine kinase signalling required for integrin αvβ5-directed cell motility but not adhesion on vitronectin. J Cell Biol 127:859-866
19. Clyman RI, Murray F, Kramer RH (1992) β1 and β3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res 200:272-284
20. Pasqualini R, Hemler ME (1994) Contrasting roles for integrin β1 and β5 cytoplasmic domains in subcellular localization, cell proliferation and cell migration. J Cell Biol 125:447-460
21. Vuori K, Ruoslahti E (1994) Association of insulin receptor substrate-1 with integrins. Science 266:1576-1578
22. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA (1992) Involvement of integrin αv gene expression in human melanoma tumourigenicity. J Clin Invest 89:2018-2022
23. Montgomery AMP, Reisfeld RA, Cheresh DA (1994) Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci 91:8856-8860
24. Gehlsen KR, Davis GE, Sriramarao P (1992) Integrin expression in human-melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 10:111-120
25. Jacob K, Bosserhoff AK, Wach F, Knuchel R, Klein EC, Hein R, Buettner R (1995) Characterisation of selected strongly and weakly invasive sublines of a primary human-melanoma cell-line and isolation of subtractive cDNA. Int J Cancer 60:668-675
26. Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJC (1992) Role of the αvβ3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89:1557-1561
27. Paulus W, Tonn JC (1994) Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80:515-519
28. Boukerche H, McGregor B, Berthiers-Vergnes O, McGregor J (1993) The role of the αvβ3 integrin (vitronectin receptor) in platelet-melanoma interaction and metastasis. Nouv Rev Fr Hematol 35:267-268
29. Boukerche H, Berthier-Vergnes O, Dore JF, Leung LLK, McGregor JL (1989) A monoclonal antibody (LYP18) directed against blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo Blood. 74:909-912
30. Thomas L, Chan PW, Chang S, Damsky C (1993) 5-Bromo-2-deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell. J Cell Sci 105:191-201
31. Nip J, Shibata H, Loskutoff DJ, Cheresh DA, Brodt P (1992) Human melanoma cells derived from lymphatic metastases use integrin αvβ3 to adhere to lymph node vitronectin. J Clin Invest 90:1406-1413
32. Filardo EJ, Brooks PC, Deming SL, Damsky C, Cheresh DA (1995) Requirement of the NPXY motif in the integrin (53 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J Cell Biol 130:441-450
33. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovch L, Herlyn M, Buck CA (1990) Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression. Cancer Res 50:6757-6764
34. Marshall JF, Nesbitt SA, Helfrich MH, Horton MA, Polakova K, Hart IR (1991) Integrin expression in human melanoma cell lines: Heterogeneity of vitronectin receptor composition and function. Int J Cancer 49:924-931
35. Boukerche H, Benchaibi M, Berthier-Vergnes O, Lizard G, Bailly M, McGregor JL (1994) Two human melanoma cell-line variants with enhanced in-vivo tumour growth and metastatic capacity do not express the β3 integrin subunit. Eur J Biochem 220:485-491
36. Danen EHJ, Jansen KFJ, Van Kraats AA, Cornelissen MHA, Ruiter DJ, Muijen GNP (1995) αv-integrins in human melanoma: Gain of αvβ3 and loss of αvβ5 are related to tumour progression in situ but not to metastatic capacity of cell lines in nude mice. Int J Cancer 61:491-496
37. Pignatelli M, Stamp G (1995) Integrins in Tumour Development, in Cancer Surveys: Cell Adhesion and Cancer (Hart I, Hogg N, eds) pp 113-127. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, USA
38. Weinacker A, Chen A, Agrez M, Cone RI, Nishimura S, Wayner E, Pytela R, Sheppard D (1994) The role of integrin αvβ6 in cell attachment to fibronectin -heterologous expression of intact and secreted forms of the receptor. J Biol Chem 269:6940-6948
39. Agrez M, Chen A, Cone RI, Pytela R, Sheppard D (1994) The αvβ6 integrin promotes proliferation of colon-carcinoma cells through a unique region of the β6 cytoplasmic tail. J Cell Biol 127:547-556
40. Moyle M, Napier MA, McLean JW (1991) Cloning and expression of a divergent integrin subunit β8. J Biol Chem 266:19650-19658
41. Breuss JM, Gillett N, Lu L, Sheppard D, Pytela R (1993) Restricted distribution of integrin β6 mRNA in primate epithelial tissues. J Histochem Cytochem 41:1521-1527
42. Koukolis GK, Virtanen I, Korhonen M, Quaranta V, Gould VE (1991) Immunohistochemical localisation of integrins in the normal, hyperplastic and neoplastic breast. Am J Pathol 139:787
43. Mechtersheimer G, Barth T, Hartschuh W, Lehnert T, Moller P (1994) In-situ expression of β1, β3 and β4 integrin subunits in non-neoplastic endothelium and vascular tumours. Virch Archiv Int J Path 1994:375-384
44. Korhonen M, Laitinen L, Ylanne J, Koukolis GK, Quaranta V, Juusela H, Gould VE, Virtanen I (1992) Integrin distribution in renal cell carcinomas of various grades of malignancy. Am J Pathol 141:1161-1171
45. Droz D, Patey N, Paraf F, Chretien X Gogusev J (1994) Composition of extracellular-matrix and distribution of cell-adhesion molecules in renal-cell cancer. Lab Investig 71:710-718
46. Gladson CL, Cheresh DA (1991) Glioblastoma expression of vitronectin and the αvβ3 integrin: Adhesion mechanism for transformed glial cells. J Clin Invest 88:1924-1932
47. McGregor BC, McGregor JL, Weiss LM, Wood GS, Hu C-H, Boukerche H, Warnke RA (1989) Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol 92:495-499
48. Si Z, Hersey P (1994) Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and 'selectins' on melanoma cells. Pathology 26:6-15
49. Danen EHJ, ten Berge PJM, van Muijen GNP, van Thofgrootenboer AE, Brocker EB, Ruiter DJ (1994) Emergence of α5β1 fibronectin receptor and αvβ3 vitronectin-receptor expression in melanocytic tumour progression. Histopath 24:249-256
50. Natali PG, Nicotra MR, Difillipo F, Bigotti A (1995) Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer 71:1243-1247
51. ten Berge PJM, Danen EHJ, van Muijen GNP, Jager MJ, Ruiter DJ (1993) Integrin expression in uveal melanoma differs from cutaneous melanoma. Investig Opthalmol Vis Sci 34:3635-3640
52. Humphries MJ, Olden K, Yamada KM (1986) A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233:4674-70
53. Saiki I, Murata J, Iida J, Nishi N, Sugimura K, Azuma I (1989) The inhibition of murine lung metastasis by synthetic polypeptides [poly(arg-gly-asp) and poly(tyr-ile-gly-ser-arg)] with a core sequence of cell adhesion molecules. Br J Cancer 59:194-197
54. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S (1973) Platelet tumor interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 11:704
55. Blasi F (1993) Urokinase and urokinase receptor - a paracrine autocrine system regulating cell-migration and invasiveness. Fibrinolysis 7:17-18
56. Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ (1995) Up-regulation of urokinase and urokinase-receptor genes in malignant astrocytoma. Am J Path 146:1150-1160
57. Myohanen HT, Stephens RW, Hedman K, Tapiovaara H, Ronne E, Hoyerhansen G, Dano K, Vaheri A (1993) Distribution and lateral mobility of the urokinase-receptor complex at the cell-surface. J Histochem Cytochem 41:1291-1301
58. Ciambrone GJ, McKeown-Longo PJ (1992) Vitronectin regulates the synthesis and localisation of urokinase-type plasminogen activator in HT-1080 cells. J Biol Chem 267:13617-13622
59. Waltz DA, Chapman HA (1994) Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269:14746-14750
60. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380-32388
61. Salonen E-M, Vaheri A, Pollanen J, Stephens R, Andreasen P, Mayer M, Dano K, Gailit J, Ruoslahti E (1989) Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 264:6339-6343
62. Cubellis MV, Wun T-C, Blasi F (1990) Receptor mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9:1079-1085
63. Nip J, Rabbani SA, Shibata HR, Brodt P (1995) Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen-activator receptor in metastatic melanoma-cells. J Clin Invest 95:2096-2103
64. Quax PHA, van Muijen GNP, Pedersen D, de Bart ACW, Schrauwen Y, Barlovatz-Meimon G, Blasi F, Verheijen JH (1992) The plasminogen-activator system in extracellular-matrix degradation. Fibrinolysis 6:4144
65. Mueller BM, Yu YB, Laug WE (1995) Overexpression of plasminogen-activator inhibitor-2 in human-melanoma cells inhibits spontaneous metastasis in scid/ scid mice. Proc Natl Acad Sci USA 92:205-209
66. de Vries TJ, Quax PHA, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, van Muijen GNP (1993) Plasminogen activators, their inhibitors and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70-81
67. Delbaldo C, Masouye I, Saurat J-H, Vassalli J-D, Sappino A-P (1994) Plasminogen activation in melanocytic neoplasia. Cancer Res 54:4547-4552
68. de Vries TJ, Mooy CM, Van Balken MR, Luyten GBM, Quax PHA, Verspaget HW, Weidle UH, Ruiter DJ, van Muijen GNP (1995) Components of the plasminogen activation system in uveal melanoma: a clinicopoathological study. J Path 175:59-67
69. Ray JM, Stetler-Stevenson WG (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14:908-917
70. Montgomery AMP, Declerck YA, Langley KE, Reisfeld RA, Mueller BM (1993) Melanoma-mediated dissolution of extracellular-matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res 53:693-700
71. Stahl A, Mueller BM (1994) Binding of urokinase to its receptor promotes migration and invasion of human-melanoma cells in vitro. Cancer Res 54:3066-3071
72. De Clerck YA, Imren S (1994) Protease inhibitors: Role and potential therapeutic use in human cancer. Eur J Cancer 30:2170-2180
73. Dahlback K, Lofberg H, Dahlback B (1986) Localisation of vitronectin (S-protein of complement) in normal human skin. Acta Dermatol Venereol (Stockh) 66:461-467
74. Weinstrup RJ, Murad S, Pinnel SR (1991) Collagen, in Physiology, Biochemistry and Molecular Biology of the Skin (Goldsmith, LA, ed.) pp 481-508. Oxford University Press
75. Davis GE (1992) Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun 182:1025-1031
76. Bartfeld NS, Pasquale EB, Geltosky JE, Languino LR (1993) The αvβ3 integrin associates with a 190-kDa protein that is phosporylated on tyrosine in response to platelet-derived growth factor. J Biol Chem 268:17270-17276
77. Schwartz MA (1994) Integrins as signal transducing receptors, in Integrins; Molecular and Biological Responses to the Extracellular Matrix (Cheresh DA, Mecham RP, eds) pp 3347. Academic Press, London
78. Bhattcharya S, Fu C, Bhattcharya J, Greenberg S (1995) Soluble ligands of the αvβ3 integrin mediate enhanced tyrosine phosphorylation of multiple proteins in adherent bovine pulmonary artery endothelial cells. J Biol Chem 270:16781-16787
79. Lindberg FP, Gresham HD, Schwarz E, Brown EJ (1993) Molecular cloning of integrin-associated protein: An immunoglobulin family member with multiple membrane-spanning domains implicated in αvβ3-dependent ligand binding. J Cell Biol 123:484-496
80. Brown E, Hooper L, Ho T, Gresham H (1990) Integrin-associated protein: A 50 kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 111:2785-2794
81. Schwartz MA, Denninghoff K (1994) αv-integrins mediate the rise in intracellular calcium in endothelial-cells on fibronectin even though they play a minor role in adhesion. J Biol Chem 269
82. Schwartz MA, Brown EJ, Fazeli B (1993) A 50 kDa integrin-associated protein is required for integrin-regulated calcium-entry in endothelial-cells. J Biol Chem 268:19931-19934
83. Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61
84. Brooks PC, Clark RAF, Cheresh DA (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569-571
85. 3 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164